C4 Therapeutics Cash Flow Statement (2019-2026) | CCCC

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-24.68M-15.66M-31.62M-128.67M-31.96M-37.19M-34.78M-35.92M-27.04M-34.76M-28.36M-17.72M-24.67M-34.57M-26.32M-26.02M-32.17M-20.36M-27.45M-24.08M
Depreciation and Depletion (Quarter)
0.33M0.32M0.30M0.43M0.41M0.52M0.55M0.46M0.45M0.13M0.38M0.30M0.36M0.36M0.36M0.42M0.38M0.38M0.36M0.34M
Share-based Compensation (Quarter)
6.09M21.51M44.07M-26.98M6.01M20.97M6.25M6.42M8.20M6.36M6.21M6.38M8.83M8.23M5.51M4.99M4.59M4.01M2.67M3.04M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
10.73M
Cash from Operations (Quarter)
-18.36M-25.67M-26.60M-22.20M-28.02M-29.13M-33.12M-19.00M-30.71M-24.01M-18.12M-4.97M-24.13M-17.93M-33.28M-12.06M-31.21M-22.14M-29.94M-1.57M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.39M-0.85M0.18M0.18M-1.47M0.40M0.18M1.55M1.09M-2.41M1.26M1.67M1.39M1.08M0.78M0.58M0.52M0.86M1.09M0.19M
Amortization of Deferred Charges (Quarter)
0.33M0.43M1.18M1.71M1.50M1.50M1.52M1.53M1.55M1.56M1.58M1.60M1.61M1.63M1.65M1.67M1.69M1.43M1.44M1.45M
Depreciation & Amortization (CF) (Quarter)
0.33M0.32M0.30M0.43M0.41M0.52M0.55M0.46M0.45M0.43M0.45M0.45M0.44M0.48M0.46M0.61M0.46M0.43M0.40M0.29M
Change in Working Capital
Change in Receivables (Quarter)
-1.37M0.87M-3.94M-0.06M-0.22M-0.01M-0.94M0.50M-0.53M11.30M1.80M-12.43M9.17M-7.24M4.93M-5.83M4.34M-4.14M0.48M-1.55M
Change in Account Payables (Quarter)
-0.60M0.76M-1.15M0.59M-1.69M-1.08M-0.14M1.08M-0.84M0.17M0.18M-0.71M0.59M-0.18M-0.65M1.53M-0.89M-0.47M-0.09M0.35M
Change in Accured Expenses (Quarter)
1.93M2.13M-3.77M3.68M2.48M2.69M-3.67M0.54M-0.73M5.18M-7.66M-1.75M4.17M3.98M-6.73M0.63M-2.02M2.07M-3.52M3.99M
Other Working Capital Changes (Quarter)
-11.17M-15.06M-0.31M-15.70M-5.27M20.89M-2.73M7.84M-10.57M2.74M18.56M-2.35M-4.08M-7.80M-0.34M-3.63M-6.18M9.01M-0.12M14.81M
Investing Activities
Capital Expenditures (Quarter)
-1.17M0.17M0.53M3.31M1.49M0.59M0.36M0.60M0.16M0.01M0.17M-0.00M0.18M-0.16M0.58M0.04M0.04M
Change in Acquisitions & Divestments (Quarter)
54.08M86.11M72.39M65.67M78.33M67.06M65.56M64.15M90.27M69.98M54.35M55.72M68.71M54.45M54.77M60.79M51.18M52.35M57.03M56.05M
Cash from Investing Activities (Quarter)
-100.63M-59.41M-4.00M33.23M19.91M9.28M53.53M15.15M57.73M31.95M-53.40M-11.71M0.16M13.67M29.12M38.92M4.09M-80.73M16.15M-14.81M
Financing Activities
Other financing activities (Quarter)
-0.53M-0.29M0.26M-0.04M0.51M-0.36M0.10M-0.05M0.08M0.30M0.00M0.11M-0.11M0.11M0.60M0.18M
Cash from Financing Activities (Quarter)
0.58M0.47M0.48M0.26M0.36M0.05M-0.68M-0.75M-10.75M57.67M34.58M0.14M10.51M0.11M-0.05M7.77M118.67M0.46M33.73M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
57.70M14.09M5.91M82.30M7.53M
Additional items
Change in Cash (Quarter)
-118.40M-84.62M-30.12M11.29M-7.75M-19.80M19.72M-4.59M16.27M65.61M-36.93M-16.55M-13.46M-4.15M-4.21M26.86M-19.35M15.79M-13.33M17.34M
Free Cash Flow (Quarter)
-17.19M-25.67M-26.77M-22.72M-31.32M-30.62M-33.71M-19.36M-31.31M-24.17M-18.12M-4.99M-24.30M-17.93M-33.28M-12.24M-31.05M-22.73M-29.98M-1.61M
Net Cash Flow (Quarter)
-118.40M-84.62M-30.12M11.29M-7.75M-19.80M19.72M-4.59M16.27M65.61M-36.93M-16.55M-13.46M-4.15M-4.21M26.86M-19.35M15.79M-13.33M17.34M